First of June of 2021, marked a huge milestone on obesity.
Included in the International Classification of diseases in 1948, recognized by the WHO only in 1997, it took 24 years to the UE to recognize obesity as a Chronic Disease, understanding this is the first step but a very important one.
Now we must see how general practitioners will fill all the gaps in order to define a treatment protocol, like any other disease.
The general public will now understand those extra kilos we earned during the last 18 months is not just a few more beers or less sport due to the lockdown we suffered, but it is something much deeper, like cholesterol or other disease that arise from bad habits and converted into a major health concern.
Metabolic syndrome, a blend between obesity and other factors, will now a key point for nutraceutical, as, per definition, a nutraceutical product aims to prevent a major health problem. METABOLAID® is here to support metabolic syndrome and prevent major diseases.
This is the right moment, it’s METABOLAID® mome
Source:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00145-5/fulltext
